Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718)430-2601 E:

Slides:



Advertisements
Similar presentations
Nicotine Gum Nicotine absorbed mucosal membranes 2mg and 4mg strength
Advertisements

A Clinical Flow-Chart for the “Treatment-Resistant Smoker”
Bronx BREATHES: Resources and Technical Assistance for Improved Tobacco Treatment Barbara Hart, MPA David Lounsbury, PhD Claudia Lechuga, MS Hal Strelnick,
Nicotine Addiction Pharmacy Practice II Winter 2005.
STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
Treatment of Tobacco Dependence in 2012 J. Taylor Hays, MD Professor of Medicine Associate Director Nicotine Dependence Center Mayo Clinic Rochester, MN.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Tobacco Smoking tobacco in any way (cigarettes, cigars, hookah) is bad for your health. Large companies use the media to persuade people into thinking.
All About Smoking Cessation Going for the 3 Increases: Increase in Health, Increase in Happiness & Increase in Energy Strategies for Success in Health.
Prevention strategies
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Treating Nicotine Dependence in Patients with Addictive Disorders Eric Heiligenstein, M.D. Director of Psychiatry University Health Services University.
Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.
QUIT NOW. BARRIERS TO QUITTING Nicotine is a potent psychoactive drug that causes physical dependence and tolerance. In the absence of nicotine, a smoker.
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
SMOKING CESSATION Leading Preventable Cause of Death 400,000 to 500,000 deaths per year in USA 3 Million deaths world wide 1 of every 6 deaths in USA Directly.
Tobacco Facts Causes illness and death But it’s avoidable Linked to: Multiple cancers Heart disease Stroke Complications of pregnancy Chronic obstructive.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.
Nancy Rigotti, MD Treatment Review: Overview of the Evidence Base for Tobacco Dependence Treatment 10/09/2011.
Module 2 - Assessment, Diagnosis, and Pharmacotherapy: Integrating Tobacco Use Interventions into Chemical Dependence Services.
Quitting Smoking How to stop smoking … for good!.
Smoking Cessation for Pregnancy and Beyond: Virtual Clinic Companion Slides Catherine A. Powers, EdD, LSW PACE – Tobacco Prevention and Cessation Education.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
Choosing to Live Tobacco- Free Teens and Tobacco Benefits of living Tobacco-Free Quitting Tobacco Use.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Quit For Life® Program Presented by Helen Farid 1.
Clearing the Air: What You Need to Know and Do to Prepare to Quit Smoking Getting Ready to Quit Course May,2011 Sponsored by: Baltimore County Health Department.
Tobacco Myths- Up in Smoke (American Cancer Society) HS 460.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
An Updated Algorithm for Choosing Among Smoking Cessation Treatments John R. Hughes University of Vermont, USA
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
TOBACCO USE & OLDER SMOKERS. OLDER SMOKERS In 2004, 3.7 million people aged 65 and older were smokers and 16% of all people aged 50 and older smoked;
Laws/Policies ABSTRACT Problem: A challenge for tobacco control practitioners is getting smokers to quit using cessation methods. To increase the proportion.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
July 2006 Treating Tobacco Use and Dependence. Learning Objectives At the end of this session you should understand: The impact of tobacco dependence.
SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.
Freshstart. Freshstart: Welcome! Congratulations! What is the Freshstart program? Session One Objective Nicotine Dependence and Addiction Physiological.
Melissa Natzke Doctor of Pharmacy Candidate
Attempting to increase the use of smoking cessation medications Brendon Baker Ministry of Health.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
-Tobacco is the leading preventable cause of disease, disability, and death in the United States (NIDA, 2012). -About 1 in every 5 deaths in the U.S. result.
1 Access to and use of aids to smoking cessation in the UK Robert West University College London Austin, Texas February 2007.
1 Treating Nicotine Dependency Paul Zemann Public Health - Seattle & King County Tobacco Prevention Program th Ave, Suite 900 Seattle, WA 98104
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
1 Advising smokers on optimum pharmacotherapy for smoking cessation University College London April 2014 Robert West.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
1 Smoking and health University College London 2010 Robert West.
Smoking. Why people smoke and find it difficult to stop Smoking is an addictive habit. It is associated with strong cravings, dependency, tolerance, and.
AN EXAMINATION OF THE PRACTICE OF TAILORING SMOKING CESSATION PHARMACOTHERAPY IN A TOBACCO TREATMENT PROGRAM WITHIN MENTAL HEALTH AND ADDICTIONS SETTINGS.
Quick overview of quit smoking counseling for people with mental health or substance use disorders Associate Professor of.
Smoking Cessation Medication
Anita R. Webb, PhD JPS Family Medicine Residency
screening, brief intervention, and referral to treatment
Assistant professor Family Medicine - Suez Canal University
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
FDA Authority to Regulate Tobacco Products Tobacco Control Act
Why and How to Quit Smoking
Changes to the UK licence for NRT: rationale
Get smoker to their baseline for their behavioral health condition and initiating abstinence from substances. Then assess whether, in the past year, was.
Tobacco Cessation Guidelines for COPD
Forming a Tobacco Addiction
Smoking cessation Felix K. Karthik.
ABCs of Behavioral Support
Weed Out the Need.
Presentation transcript:

Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718) E: / June 15, 2009

Smoker Assessment History of usage Previous quit attempts – Withdrawal/abstinence symptoms Motivational level for quit attempt Current social environment – Stressors – Triggers – Biological/medical assessment – Family and friend support/sabotage

Previous Quit Attempts Dates Age Method used to quit – Medications or counseling used (if any) Duration of that method Problems and successes experienced Reason for relapse Withdrawal/Abstinence Symptoms

Current Quit Attempt Motivational Level – Confidence Main reason for considering/wanting to stop Concerns about quitting – Weight gain concerns

Use of NRT Reasons for using NRT Doubles the success rate Treats nicotine withdrawal – Helps patient feel more comfortable Safe – Patient receiving same drug (nicotine) in a less addictive form over a relatively short period Reasons for NOT using NRT Medical conditions requiring caution/physician input – i.e. recent MI, pregnancy, current arrythmia Age – Under 18s require physician/parental input Specific issues – Allergy to patches – Personal aversion to medication Questionable efficacy – i.e. those smoking less than 10pd

Tobacco Cessation Medications Nicotine Replacement Patch * Gum * Lozenge * Oral Inhaler ^ Nasal Spray ^ Non-nicotine medication Bupropion ^ – (Zyban/Wellburtrin) Varenicline ^ – (Chantix) * Available OTC ^ prescription only

Nicotine Delivery Comparison

Medication Overview

Use and Efficacy of combination therapy Multiple patch therapy (42 vs 21mg) – 20% increased abstinence – No significant increased sleep disturbances – (Dale 1995; Jorenby 1995) Patch + Gum – Kornitzer 1995; Puska 1995 Early better rates – 7% increase at 6 months Not sustained at 1 year No increase in adverse events – 2008 OHS Guidelines Meta-analysis Path + Gum/Spray OR = 1.9 – Compared to patch alone (OR=1) – Fiore 2008 Abstinence rates – Nicotine Patch = 23.4% – Nicotine Gum = 19.0% – Long term Patch + Gum = 36.5%

Important Points about NRT Nicotine is the addictive part of tobacco smoke but NOT the most dangerous part People do NOT generally become addicted to medication People DON’T use enough medication or stop TOO EARLY – Medications are SAFE and EFFECTIVE – Plan on minimum of 2 months of medication Combinations – Work better than single medications Use Long acting + Short acting

NRT Kits Available Moderate Smokers Smoke per day Includes: – Novartis Step 1 28 count 21 mg patches Heavy Smokers Smoke 20+ per day Includes : – Nicorelief Gum 110 pieces of 4mg gum – Novartis Step 1 28 count of 21mg patches

NRT Enrollment Forms  Necessary for each course distributed  Full information required  Fax or back to Bronx BREATHES

NRT Enrollment Forms (cont’d 1)